Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Cephalothin (DBL)

Cephalothin (DBL) is a medicine containing the active ingredient(s) cefalotin. On this page you will find out more about Cephalothin (DBL), including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: cefalotin

Information for medicine and pack size:
Cephalothin (DBL) 1 g powder for injection, 10 vials

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

INDICATIONS: Cephalothin Sodium for injection is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. Culture and susceptibility studies should be performed. However, therapy may be instituted before results of susceptibility studies are obtained (see PHARMACOLOGY: Microbiology). Respiratory tract: Infections caused by S. pneumoniae, Staphylococci (penicillinase and nonpenicillinase producing), group A Beta-haemolytic Streptococci, Klebsiella, and H. influenzae. Skin and soft tissue: Infections, including peritonitis, caused by Staphylococci (penicillinase and nonpenicillinase producing), group A Beta-haemolytic Streptococci, E.coli, Pr. mirabilis and Klebsiella. Genitourinary tract: Infections caused by E. coli, Pr. mirabilis and Klebsiella. Septicaemia, including endocarditis: Infections caused by S. pneumoniae, Staphylococci (penicillinase and nonpenicillinase producing), group A Beta-haemolytic Streptococci, S. viridans, E. coli, Pr. mirabilis and Klebsiella. Bone and joint: Infection caused by Staphylococci (penicillinase and non-penicillinase producing). Prophylactically in vaginal hysterectomy, head and neck surgery, insertion of prosthetic heart valves, and prosthetic arthroplasty. Cephalothin is not recommended for gastrointestinal procedures or other sites where anaerobic organisms such as Bacteriodes tend to prevail. Dosage is required pre-, intra-and postoperatively (i.e perioperatively, see DOSAGE AND ADMINISTRATION). If signs of postoperative infection develop, specimens should be cultured to identify the causative organism so that appropriate therapy can be instituted. NOTE: If the susceptibility tests show that the causative organism is resistant to cephalothin, other appropriate antibiotic therapy should be instituted.

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance white to almost white powder or plug in a 10mL type III clear glass vial, with a rubber stopper closure and aluminium flip-off top.
Dosage Form Injection, powder for
Route of administration Intravenous
Medicine schedule
10 x 10mL vial: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store below 25 degrees Celsius
Storage conditions No information available
Life time 3 Years
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 May 2018

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo